Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Risk Evaluation and Mitigation Strategy (REMS)
Marketing
FDA plans to expand pharma's opioid-education duties
Opioid makers face a task that’s partly old, partly new. Besides training docs on their meds' risks, they'd have to include info on rival therapies.
Tracy Staton
Jul 12, 2017 10:14am
Biogen, AbbVie confront EU action on Zinbryta safety
Jul 10, 2017 10:46am
New FDA commissioner Gottlieb unveils price-fighting strategies
May 26, 2017 9:14am
Senators take aim at drugmakers that use REMS to block competition
Jun 15, 2016 9:38am
